Medpace Holdings Revenue 2014-2025 | MEDP
Medpace Holdings annual/quarterly revenue history and growth rate from 2014 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Medpace Holdings revenue for the quarter ending March 31, 2025 was $0.559B, a 9.3% increase year-over-year.
- Medpace Holdings revenue for the twelve months ending March 31, 2025 was $2.157B, a 9.87% increase year-over-year.
- Medpace Holdings annual revenue for 2024 was $2.109B, a 11.84% increase from 2023.
- Medpace Holdings annual revenue for 2023 was $1.886B, a 29.17% increase from 2022.
- Medpace Holdings annual revenue for 2022 was $1.46B, a 27.8% increase from 2021.
Medpace Holdings Annual Revenue
(Millions of US $) |
| 2024 |
$2,109 |
| 2023 |
$1,886 |
| 2022 |
$1,460 |
| 2021 |
$1,142 |
| 2020 |
$926 |
| 2019 |
$861 |
| 2018 |
$705 |
| 2017 |
$436 |
| 2016 |
$422 |
| 2015 |
$359 |
| 2014 |
$326 |
| 2013 |
$273 |
Medpace Holdings Quarterly Revenue
(Millions of US $) |
| 2025-03-31 |
$559 |
| 2024-12-31 |
$537 |
| 2024-09-30 |
$533 |
| 2024-06-30 |
$528 |
| 2024-03-31 |
$511 |
| 2023-12-31 |
$498 |
| 2023-09-30 |
$492 |
| 2023-06-30 |
$461 |
| 2023-03-31 |
$434 |
| 2022-12-31 |
$394 |
| 2022-09-30 |
$384 |
| 2022-06-30 |
$351 |
| 2022-03-31 |
$331 |
| 2021-12-31 |
$309 |
| 2021-09-30 |
$296 |
| 2021-06-30 |
$278 |
| 2021-03-31 |
$260 |
| 2020-12-31 |
$260 |
| 2020-09-30 |
$230 |
| 2020-06-30 |
$205 |
| 2020-03-31 |
$231 |
| 2019-12-31 |
$230 |
| 2019-09-30 |
$216 |
| 2019-06-30 |
$214 |
| 2019-03-31 |
$201 |
| 2018-12-31 |
$192 |
| 2018-09-30 |
$179 |
| 2018-06-30 |
$170 |
| 2018-03-31 |
$163 |
| 2017-12-31 |
$113 |
| 2017-09-30 |
$111 |
| 2017-06-30 |
$106 |
| 2017-03-31 |
$107 |
| 2016-12-31 |
$108 |
| 2016-09-30 |
$108 |
| 2016-06-30 |
$106 |
| 2016-03-31 |
$100 |
| 2015-12-31 |
|
| 2015-09-30 |
$92 |
| 2014-12-31 |
|
| 2013-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Services |
$9.298B |
$2.109B |
|
Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
| Danaher (DHR) |
United States |
$146.605B |
27.50 |
| CVS Health (CVS) |
United States |
$81.948B |
10.19 |
| Elevance Health (ELV) |
United States |
$76.969B |
9.93 |
| Cencora (COR) |
United States |
$57.219B |
19.91 |
| DiDi Global (DIDIY) |
China |
$24.191B |
25.70 |
| Natera (NTRA) |
United States |
$21.906B |
0.00 |
| Labcorp Holdings (LH) |
United States |
$20.893B |
16.95 |
| bioMerieux (BMXMF) |
FR |
$16.861B |
0.00 |
| EUROFINS SCIENT (ERFSF) |
Luxembourg |
$13.687B |
0.00 |
| CochLear (CHEOY) |
Australia |
$12.827B |
0.00 |
| Solventum (SOLV) |
United States |
$12.768B |
13.52 |
| ICON (ICLR) |
Ireland |
$12.156B |
11.30 |
| Revvity (RVTY) |
United States |
$11.964B |
20.59 |
| Viatris (VTRS) |
United States |
$10.704B |
3.68 |
| Avantor, Inc. (AVTR) |
US |
$9.254B |
13.45 |
| Sonic Healthcare (SKHHY) |
Australia |
$8.886B |
0.00 |
| HealthEquity (HQY) |
United States |
$8.174B |
35.80 |
| Charles River Laboratories (CRL) |
United States |
$7.829B |
15.34 |
| Caris Life Sciences,�Inc. (CAI) |
US |
$6.744B |
0.00 |
| Amplifon S.p.A. (AMFPF) |
IT |
$5.378B |
29.44 |
| Bausch + Lomb Corporation (BLCO) |
CA |
$4.911B |
28.92 |
| BrightSpring Health Services, Inc. (BTSG) |
US |
$3.571B |
32.76 |
| Sotera Health (SHC) |
United States |
$3.349B |
19.03 |
| Surgery Partners (SGRY) |
United States |
$2.825B |
36.73 |
| Alignment Healthcare, Inc. (ALHC) |
US |
$2.645B |
0.00 |
| Organon (OGN) |
United States |
$2.584B |
2.75 |
| Concentras Parent (CON) |
United States |
$2.551B |
14.74 |
| GeneDx Holdings (WGS) |
United States |
$2.356B |
90.72 |
| Ardent Health, Inc. (ARDT) |
US |
$2.027B |
8.64 |
| Progyny (PGNY) |
United States |
$1.990B |
43.79 |
| PACS (PACS) |
United States |
$1.932B |
0.00 |
| Premier (PINC) |
United States |
$1.736B |
13.18 |
| GoodRx Holdings (GDRX) |
United States |
$1.695B |
33.89 |
| Teladoc Health (TDOC) |
United States |
$1.460B |
0.00 |
| Establishment Labs Holdings (ESTA) |
|
$1.298B |
0.00 |
| Pediatrix Medical (MD) |
United States |
$1.127B |
8.58 |
| CareDx (CDNA) |
United States |
$1.121B |
17.50 |
| Ryman Healthcare (RYHTY) |
New Zealand |
$0.970B |
0.00 |
| Agilon Health, Inc. (AGL) |
US |
$0.923B |
0.00 |
| QDM (QDMI) |
Hong Kong, SAR China |
$0.848B |
291.00 |
| AMN Healthcare Services Inc (AMN) |
US |
$0.810B |
7.58 |
| Nutex Health (NUTX) |
United States |
$0.637B |
9.64 |
| Embecta (EMBC) |
United States |
$0.612B |
4.12 |
| InnovAge Holding (INNV) |
United States |
$0.559B |
0.00 |
| SBC Medicals (SBC) |
United States |
$0.523B |
0.00 |
| LifeMD (LFMD) |
United States |
$0.512B |
0.00 |
| Sonida Senior Living (SNDA) |
United States |
$0.482B |
0.00 |
| Auna S.A. (AUNA) |
LU |
$0.471B |
10.60 |
| Omada Health (OMDA) |
|
$0.455B |
0.00 |
| So-Young (SY) |
China |
$0.390B |
0.00 |
| Enhabit (EHAB) |
United States |
$0.357B |
29.38 |
| COMPASS Pathways (CMPS) |
United Kingdom |
$0.344B |
0.00 |
| Performant Healthcare (PHLT) |
United States |
$0.321B |
0.00 |
| Oncology Institute (TOI) |
United States |
$0.279B |
0.00 |
| Beauty Health (SKIN) |
United States |
$0.241B |
0.00 |
| DocGo (DCGO) |
United States |
$0.152B |
24.83 |
| Pheton Holdings (PTHL) |
China |
$0.138B |
0.00 |
| Sera Prognostics (SERA) |
United States |
$0.107B |
0.00 |
| Ascend Wellness Holdings, Inc. (AAWH) |
US |
$0.079B |
0.00 |
| KindlyMD (NAKA) |
United States |
$0.074B |
0.00 |
| IceCure Medical (ICCM) |
Israel |
$0.061B |
0.00 |
| NeueHealth (NEUE) |
United States |
$0.061B |
0.00 |
| ModivCare (MODV) |
United States |
$0.046B |
0.00 |
| Biodesix, Inc. (BDSX) |
US |
$0.045B |
0.00 |
| Basel Medical Group Ltd (BMGL) |
SG |
$0.042B |
0.00 |
| NeuroOne Medical Technologies (NMTC) |
United States |
$0.035B |
0.00 |
| OSR Holdings (OSRH) |
United States |
$0.023B |
0.00 |
| Intelligent Bio Solutions (INBS) |
United States |
$0.012B |
0.00 |
| BioNexus Gene Lab Corp. (BGLC) |
|
$0.009B |
0.00 |
| Co-Diagnostics (CODX) |
United States |
$0.008B |
0.00 |
| SeaStar Medical Holding (ICU) |
United States |
$0.007B |
0.00 |
| XWELL (XWEL) |
United States |
$0.005B |
0.00 |
| Aclarion, Inc. (ACON) |
US |
$0.004B |
0.00 |
| NewGenIvf Group (NIVF) |
Thailand |
$0.003B |
0.00 |
| ISpecimen (ISPC) |
United States |
$0.003B |
0.00 |
| INVO Fertility (IVF) |
United States |
$0.002B |
0.00 |
| Cano Health (CANOQ) |
United States |
$0.000B |
0.00 |
